HONG KONG PHARMA DIGITAL TECHNOLOGY HOLDINGS LIMITED ORDINARY SHARES
NASDAQ: HKPD (Hong Kong Pharma Digital Techno)
Last update: 1 hour ago1.17
0.08 (7.34%)
Previous Close | 1.09 |
Open | 1.10 |
Volume | 1,277,286 |
Avg. Volume (3M) | 1,006,936 |
Market Cap | 12,870,000 |
Price / Earnings (TTM) | 6.88 |
Price / Sales | 0.520 |
Price / Book | 2.03 |
52 Weeks Range |
Profit Margin | 9.19% |
Operating Margin (TTM) | 9.24% |
Diluted EPS (TTM) | 0.170 |
Quarterly Revenue Growth (YOY) | 58.20% |
Quarterly Earnings Growth (YOY) | 232.70% |
Total Debt/Equity (MRQ) | 43.88% |
Current Ratio (MRQ) | 2.46 |
Market Trend
Short Term | Medium Term | ||
Industry | Pharmaceutical Retailers (US) | Mixed | Mixed |
Pharmaceutical Retailers (Global) | Bearish | Mixed | |
Stock | Hong Kong Pharma Digital Techno | - | - |
AIStockmoo Score
Analyst Consensus | 0.0 |
Insider Activity | NA |
Price Volatility | -2.0 |
Technical Moving Averages | 0.0 |
Technical Oscillators | 2.0 |
Average | 0.00 |
Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and (ii) OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China’s OTC pharmaceutical cross-border e-commerce market. |
|
Sector | Healthcare |
Industry | Pharmaceutical Retailers |
% Held by Insiders | 68.01% |
Date | Type | Details |
---|---|---|
28 Mar 2025 | Announcement | Hong Kong Pharma Digital Technology Holdings Limited Reports Financial Results for the Six Months Ended September 30, 2024 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2025 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |